These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 3330150)
21. [Beta-2 microglobulin and amyloid osteoarthropathy in patients undergoing chronic hemodialysis]. Prinseau J; Baglin A; Benoit J; Leparc JM; Got C; Louis MF; Attar B; Fritel D Ann Med Interne (Paris); 1989; 140(2):94-8. PubMed ID: 2662855 [TBL] [Abstract][Full Text] [Related]
22. [Changes in the beta 2-microglobulin level during hemodialysis]. Nikitinskaia LP; Stetsiuk EA; Iarmolinskiĭ IS; Barinov AV; Kon'kova TA Urol Nefrol (Mosk); 1990; (5):29-31. PubMed ID: 2264202 [TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of the oral adsorbent AST-120 versus placebo for chronic kidney disease. Takahashi T; Reed SD; Schulman KA Nephrology (Carlton); 2008 Oct; 13(5):419-27. PubMed ID: 18518936 [TBL] [Abstract][Full Text] [Related]
24. The effect of hollow-fiber dialyzer Plivadial Altra-Flux 140 on beta-2-microglobulin removal. Kes P; Zubcić A; Ratković-Gusić I; Prsa M; Sefer S Acta Med Croatica; 1997; 51(2):105-9. PubMed ID: 9204596 [TBL] [Abstract][Full Text] [Related]
25. Indoxyl-beta-D-glucuronide and 3-indoxyl sulfate in plasma of hemodialysis patients. Agatsuma S; Sekino H; Watanabe H Clin Nephrol; 1996 Apr; 45(4):250-6. PubMed ID: 8861801 [TBL] [Abstract][Full Text] [Related]
27. Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration. Fry AC; Singh DK; Chandna SM; Farrington K Blood Purif; 2007; 25(3):295-302. PubMed ID: 17622712 [TBL] [Abstract][Full Text] [Related]
28. [Beta2-microglobulin levels in patients with renal disease on chronic hemodialysis (author's transl)]. Yorioka N; Onari K; Akiyama M; Yamakido M; Nishimoto Y Rinsho Byori; 1976 Sep; 24(9):765-9. PubMed ID: 63578 [No Abstract] [Full Text] [Related]
29. [Relation between serum levels of C-terminal fragment, beta 2 microglobulin and creatinine in patients with chronic nephropathies at different stages of the disease]. Kowalski D; Starzyk J; Kowalska K Wiad Lek; 1989 Oct 1-Nov 1; 42(19-21):1038-43. PubMed ID: 2700400 [TBL] [Abstract][Full Text] [Related]
30. A study of oral adsorbent in chronic renal failure. Koide K; Sano M; Takeda F; Momose T; Koshikawa S; Akizawa T Biomater Artif Cells Immobilization Biotechnol; 1991; 19(1):147-66. PubMed ID: 1751665 [TBL] [Abstract][Full Text] [Related]
31. [Study on the initiation time of drug treatment for chronic renal failure]. Takahashi S; Okada K Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):765-76. PubMed ID: 8377290 [TBL] [Abstract][Full Text] [Related]
32. [Hemofiltration and hemoperfusion performed in series for the purpose of removing beta 2 microglobulin]. Marangoni R; Civardi F; Savino R; Manfredi A; Masi F; Avanzi C; Lino S Cas Lek Cesk; 1989 Sep; 128(39):1217-20. PubMed ID: 2684408 [TBL] [Abstract][Full Text] [Related]
33. [What is the reason for the increase in beta-2-microglobulin levels in the blood when using cuprophane dialysis membranes?]. Sulková S; Lapcík O; Votruba T Cas Lek Cesk; 1989 Apr; 128(17):520-3. PubMed ID: 2665936 [TBL] [Abstract][Full Text] [Related]
34. Beta-2-microglobulin kinetics during paired filtration dialysis. Kes P; Zubcić A; Ratković-Gusić I; Prsa M Acta Med Croatica; 1998; 52(2):99-102. PubMed ID: 9682496 [TBL] [Abstract][Full Text] [Related]
35. First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta(2)-microglobulin in hemodialysis. Ronco C; Brendolan A; Winchester JF; Golds E; Clemmer J; Polaschegg HD; Muller TE; La Greca G ; Levin NW Blood Purif; 2001; 19(2):260-3. PubMed ID: 11150821 [No Abstract] [Full Text] [Related]
37. Long-term effects of the oral adsorbent, AST-120, in patients with chronic renal failure. Maeda K; Hamada C; Hayashi T; Shou I; Wakabayashi M; Fukui M; Horikoshi S; Tomino Y J Int Med Res; 2009; 37(1):205-13. PubMed ID: 19215692 [TBL] [Abstract][Full Text] [Related]